These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1932704)
1. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines. Berzofsky JA Semin Immunol; 1991 Jul; 3(4):203-16. PubMed ID: 1932704 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design. Berzofsky JA Princess Takamatsu Symp; 1988; 19():161-77. PubMed ID: 2479631 [TBL] [Abstract][Full Text] [Related]
3. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238 [TBL] [Abstract][Full Text] [Related]
4. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036 [TBL] [Abstract][Full Text] [Related]
5. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862 [TBL] [Abstract][Full Text] [Related]
7. Structural implications for the design of molecular vaccines. Apostolopoulos V; Yu M; McKenzie IF; Wilson IA Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650 [TBL] [Abstract][Full Text] [Related]
8. Interaction of peptide antigens and class II major histocompatibility complex antigens. Guillet JG; Lai MZ; Briner TJ; Smith JA; Gefter ML Nature; 1986 Nov 20-26; 324(6094):260-2. PubMed ID: 2946957 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413 [TBL] [Abstract][Full Text] [Related]
10. Viral peptide immunogens: current challenges and opportunities. Azizi A; Diaz-Mitoma F J Pept Sci; 2007 Dec; 13(12):776-86. PubMed ID: 17853502 [TBL] [Abstract][Full Text] [Related]
11. The interaction of antigenic peptides with the H-2Kd MHC class I molecule. Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219 [TBL] [Abstract][Full Text] [Related]
12. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Sinigaglia F; Guttinger M; Kilgus J; Doran DM; Matile H; Etlinger H; Trzeciak A; Gillessen D; Pink JR Nature; 1988 Dec 22-29; 336(6201):778-80. PubMed ID: 2462673 [TBL] [Abstract][Full Text] [Related]
13. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1. Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988 [TBL] [Abstract][Full Text] [Related]
14. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809 [TBL] [Abstract][Full Text] [Related]
15. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. Vacchio MS; Berzofsky JA; Krzych U; Smith JA; Hodes RJ; Finnegan A J Immunol; 1989 Nov; 143(9):2814-9. PubMed ID: 2478626 [TBL] [Abstract][Full Text] [Related]
16. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. Milich DR; Jones JE; McLachlan A; Houghten R; Thornton GB; Hughes JL J Immunol; 1989 Nov; 143(10):3148-56. PubMed ID: 2478619 [TBL] [Abstract][Full Text] [Related]
17. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum. Koski GK; Ploton IN; Viscidi R; Kumar N Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592 [TBL] [Abstract][Full Text] [Related]
18. "HIV-peplotion vaccine"--a novel approach to protection against AIDS by transepithelial transport of viral peptides to Langerhans cells for long-term antiviral CTL response. (A review). Becker Y Acta Microbiol Immunol Hung; 1996; 43(1):1-17. PubMed ID: 8806938 [TBL] [Abstract][Full Text] [Related]
19. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design. Amante FH; Crewther PE; Anders RF; Good MF J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494 [TBL] [Abstract][Full Text] [Related]
20. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules. Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]